Navigation Links
Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
Date:9/24/2013

Manhasset, NY (PRWEB) September 24, 2013

The Feinstein Institute for Medical Research yesterday hosted the initial meeting of the newly formed Long Island Alzheimer’s Disease Consortium, which was also attended by US Rep. Steve Israel and State Assemblyman Charles Lavine. The consortium, which was conceived by Rep. Israel and includes a group of Alzheimer’s disease experts from throughout the New York area, met to discuss what they can collectively do to improve patients’ lives.

Barring new medical breakthroughs to prevent, slow or stop the disease, and as the US population gets older and life expectancy increases, the number of people age 65 and older with Alzheimer’s will nearly triple by 2050. Furthermore, total payments for health care, long-term care and hospice for people with Alzheimer's and other dementias are projected to increase to $1.2 trillion in 2050. Even though Alzheimer’s disease is devastating, pervasive and costly, federal funding of research in this area is very low – $400 million per year is dedicated to Alzheimer’s research versus $6 billion per year for cancer research.

In search of a solution, Peter Davies, PhD, a world-renowned Alzheimer's disease researcher who leads the Litwin-Zucker Center at the Feinstein Institute, organized the Long Island Alzheimer’s Disease Consortium at the suggestion of Rep. Israel. Rep Israel and Assemblyman Lavine are collaborating with the consortium to create a ten-year bond that would allocate per year $7 of each NY tax payer’s payments to Alzheimer’s disease research. This would add up to $1 billion dedicated to Alzheimer’s disease research.

“Currently, there is no effective treatment for those who suffer from Alzheimer’s disease. To find a treatment that works takes research, and that takes financial support,” said Dr. Davies. “In this current climate, my fellow researchers and I do not have the necessary financial support. Representative Israel and Assemblyman Lavine, along with the Long Island Alzheimer’s Disease Consortium, are working to develop an environment that fosters the discovery of treatments that make a difference.”

Members of Long Island Alzheimer’s Disease Consortium who were able to attend the initial meeting include:
    -Dr. Lisa Miller from Brookhaven National Laboratory
    -Dr. Josh Dubnau from Cold Spring Harbor Laboratory
    -Drs. Peter Davies, Terry Goldberg, Concepcion Goldberg, Marc L Gordon, Jeremy Koppel, Philippe Marambaud from the Feinstein Institute
    -Drs. Helene Benveniste, Dmitry Goldgaber, William Van Nostrand and Steven O. Smith from Stony Brook University
    -Drs. Richard Rubenstein and Howard Crystal from SUNY Downstate Medical Center
    -Dr. Tom Jeitner from Winthrop Hospital

Also invited, but unable to attend, were Dr. Pavel Osten (Cold Spring Harbor) and Dr. John Robinson (Stony Brook).

The Long Island Alzheimer’s Disease Consortium is planning to meet again within the next few months to evaluate progress and next steps.

To watch a video about this story, click here.

About Peter Davies, PhD

Peter Davies, PhD, is the director of the Litwin-Zucker Research Center for the Study of Alzheimer’s Disease at The Feinstein Institute for Medical Research. The Feinstein’s Litwin Zucker Center is the only dedicated Alzheimer’s disease research facility on Long Island. Dr. Davies and his colleagues have conducted dozens of research studies and enrolled thousands of study participants in hopes of identifying new ways to detect and treat Alzheimer’s disease. For more information about the Litwin-Zucker Research Center, call (516) 562-3492.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11158489.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Feinstein Institute to receive grant to improve schizophrenia treatment
2. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
3. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Feinstein Institute researchers discover plant derivative
6. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
7. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
8. Feinstein Institute Researcher provides insight into osteoarthritis
9. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
10. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
11. Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: